Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
1996-12-5
pubmed:abstractText
The first method for solid support synthesis of all-Rp-oligo(ribonucleoside phosphorothioate)s is presented as well as attempts to increase the stereoselectivity of the key step in this approach. The synthetic strategy consists of (i) a solid support synthesis procedure, using 5'-O-(4-methoxytriphenylmethyl)-2'-O-tert-butyldimethylsilyl-ri bon ucleoside 3'-H- phosphonates, that due to stereoselectivity in the condensation step, gives oligomers with mostly Sp-H-phosphonate diesters (72-89% under standard conditions), (ii) stereospecific sulfurization with S8 in pyridine to produce oligo(ribonucleoside phosphorothioate)s enriched with internucleosidic linkages of Rp configuration, (iii) treatment of the deprotected oligonucleotides with the enzyme Nuclease P1 from Penicillium citrinum, that specifically catalyses cleavage of Sp-phosphorothioate diester linkages, which leaves a mixture of oligomers having all internucleosidic linkages as Rp-phosphorothioates, and finally (iv) isolation and HPLC purification of the full length all-Rp oligomer. Mixed sequences containing the four common nucleosidic residues up to the chain length of a heptamer were synthesized. Change of N-4-protection on the cytidine building block from propionyl to N-methylpyrrolidin-2-ylidene gave a slightly improved diastereoselectivity in H-phosphonate diester formation. Increased selectivity up to 99+% was obtained with the guanosine building block when the amount of pyridine in the coupling step was reduced.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-1383941, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-1945876, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-2036355, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-224029, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-224905, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-2411211, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-2438652, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-2470150, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-2658487, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-2726485, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-3174451, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-3273639, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-3902078, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-5079964, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-6250450, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-6301546, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-7518583, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-7885850, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-7969490, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-8127660, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-8242149, http://linkedlifedata.com/resource/pubmed/commentcorrection/8871563-8664257
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0305-1048
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3811-20
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Solid support synthesis of all-Rp-oligo(ribonucleoside phosphorothioate)s.
pubmed:affiliation
Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't